We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.02%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.55B
AUM Growth
+$1.25B
(+20%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
15.46%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$102M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$85.3M |
| 3 |
Intuit
INTU
|
+$76.5M |
| 4 |
Home Depot
HD
|
+$71.6M |
| 5 |
Cigna
CI
|
+$44.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Brazil ETF
EWZ
|
+$119M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$69M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$51.1M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$47.4M |
| 5 |
iShares MSCI India ETF
INDA
|
+$47.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.48% |
| 2 | Financials | 13.24% |
| 3 | Healthcare | 12.6% |
| 4 | Technology | 12.25% |
| 5 | Industrials | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLDX
1301
DELISTED
KLONDEX MINES LTD
KLDX
| $369K | ﹤0.01% |
159,574
-192,157
| -55% | -$468K |
|
1302
Voyager Therapeutics
VYGR
$187M
| $367K | ﹤0.01% |
+18,800
| New | +$372K |
|
1303
Trade Desk
TTD
$8.13B
| $366K | ﹤0.01% |
39,000
-29,570
| -43% | -$208K |
|
|
MNTA
1304
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $366K | ﹤0.01% |
17,879
-40,251
| -69% | -$864K |
|
|
EVBG
1305
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $365K | ﹤0.01% |
7,700
+699
| +10% | +$29.7K |
|
|
REV
1306
DELISTED
Revlon, Inc.
REV
| $365K | ﹤0.01% |
+20,784
| New | +$410K |
|
1307
SiriusPoint
SPNT
$2.98B
| $364K | ﹤0.01% |
29,124
+16,707
| +135% | +$223K |
|
|
MODV
1308
DELISTED
ModivCare
MODV
| $363K | ﹤0.01% |
+4,624
| New | +$347K |
|
1309
Prestige Consumer Healthcare
PBH
$2.35B
| $363K | ﹤0.01% |
9,471
-33,100
| -78% | -$1.12M |
|
|
LCI
1310
DELISTED
Lannett Company, Inc.
LCI
| $361K | ﹤0.01% |
6,639
+1,950
| +42% | +$123K |
|
|
CBLK
1311
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $361K | ﹤0.01% |
+13,885
| New | +$358K |
|
1312
Mercer International
MERC
$44.9M
| $358K | ﹤0.01% |
20,433
+4,933
| +32% | +$74.2K |
|
|
SPWR
1313
DELISTED
SunPower Corporation Common Stock
SPWR
| $358K | ﹤0.01% |
71,271
+23,934
| +51% | +$131K |
|
1314
Corpay
CPAY
$24.2B
| $357K | ﹤0.01% |
1,697
-40,794
| -96% | -$8.37M |
|
|
CIO
1315
DELISTED
City Office REIT
CIO
| $355K | ﹤0.01% |
+27,666
| New | +$329K |
|
|
PACW
1316
DELISTED
PacWest Bancorp
PACW
| $355K | ﹤0.01% |
7,179
-939
| -12% | -$49.1K |
|
1317
Diodes
DIOD
$4B
| $354K | ﹤0.01% |
+10,284
| New | +$338K |
|
1318
Core Laboratories
CLB
$538M
| $353K | ﹤0.01% |
2,800
-8,068
| -74% | -$982K |
|
1319
Nomad Foods
NOMD
$1.64B
| $353K | ﹤0.01% |
+18,413
| New | +$319K |
|
|
ODP
1320
DELISTED
ODP
ODP
| $353K | ﹤0.01% |
13,845
-1,302
| -9% | -$31.7K |
|
1321
Generac Holdings
GNRC
$11.9B
| $352K | ﹤0.01% |
6,800
-3,254
| -32% | -$158K |
|
1322
Pacira BioSciences
PCRX
$1.02B
| $352K | ﹤0.01% |
+10,989
| New | +$379K |
|
1323
Spyre Therapeutics
SYRE
$8.87B
| $350K | ﹤0.01% |
1,324
+900
| +212% | +$221K |
|
1324
Chord Energy
CHRD
$7.79B
| $349K | ﹤0.01% |
26,932
-83,732
| -76% | -$954K |
|
1325
HCI Group
HCI
$2.28B
| $348K | ﹤0.01% |
+8,382
| New | +$347K |
|
Similar funds
Squarepoint's Q2 2018 Portfolio in Review
As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.
- Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
- Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
- Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
- Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
- Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
- Squarepoint opened 635 new positions and closed 556 in Q2 2018.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.
Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.